Mutations in  RAS/BRAF  genes in rectal tumors: From adenomas to early carcinomas

Yu. A. Shelygin; O. A. Maynovskaya; E. G. Rybakov; V. P. Shubin; S. V. Chernyshov; S. A. Frolov; V. N. Kashnikov; N. I. Pospekhova

doi:10.1134/S1022795417080075

Mutations in RAS/BRAF genes in rectal tumors: From adenomas to early carcinomas

作者: Shelygin Y.¹, Maynovskaya O.¹, Rybakov E.¹, Shubin V.¹, Chernyshov S.¹, Frolov S.¹, Kashnikov V.¹, Pospekhova N.¹
隶属关系:
1. Ryzhikh State Scientific Center of Coloproctology
期: 卷 53, 编号 10 (2017)
页面: 1146-1151
栏目: Human Genetics
URL: https://journals.rcsi.science/1022-7954/article/view/188492
DOI: https://doi.org/10.1134/S1022795417080075
ID: 188492

如何引用文章

全文:

开放存取

##reader.subscriptionAccessGranted##
受限制的访问

订阅存取

详细
作者简介
参考
统计

详细

The frequency and spectrum of mutations in RAS/BRAF genes were studied in rectal adenomas, carcinomas in situ, and adenocarcinomas. It is shown that the frequency of KRAS mutations decreases from adenoma to adenocarcinoma; most adenomas and carcinomas in situ are heterogeneous and consist of several subclones. Possible models of colorectal cancer pathogenesis are discussed.